Three-Statement Breakdown
Not enough comparable history yet for a verdict.
CASH
+394.2%
509
TOTAL DEBT
+14.5%
18,759
NET DEBT
+12.1%
18,250
NET DEBT / ANN. EBITDA
+0.8%
6.02×
| Balance sheet | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents |
RESTATED · WAS 168
10-Q
|
153 | 140 | 32 | 452 | 164 | 227 | 103 | 509 | +394.2% |
| Accounts receivable |
NOT DISCLOSED
RESTATED · WAS 863
|
964 | 886 | 853 | 931 | 1,564 | — | — | — | — |
| Other current assets |
RESTATED · WAS 120
10-Q
|
101 | 86 | 104 | 139 | 113 | 80 | 103 | 160 | +55.3% |
| Total current assets | 2,468 | 2,331 | 2,404 | 2,627 | 3,433 | 2,839 | 2,790 | 3,472 | +24.4% | |
| Current ratio | 0.94× | 0.86× | 0.78× | 1.19× | 1.15× | 0.98× | 0.79× | 0.98× | +23.5% | |
| Property, plant & equipment |
RESTATED · WAS 21,039
10-Q
|
18,126 | 18,926 | 21,017 | 22,352 | 22,713 | 25,072 | 27,461 | 30,680 | +11.7% |
| Total assets | 24,529 | 26,837 | 29,666 | 28,753 | 31,353 | 33,517 | 35,920 | 39,941 | +11.2% | |
| Return on assets (annualized) | 2.7% | 2.5% | 2.5% | 4.7% | 2.7% | 2.6% | 2.8% | 2.7% | -4.0% | |
| Accounts payable |
NOT DISCLOSED
RESTATED · WAS 671
|
723 | 622 | 661 | 875 | 928 | — | — | — | — |
| Short-term debt |
RESTATED · WAS 1,200
10-Q
|
996 | 1,111 | 571 | 373 | 1,090 | 975 | 1,192 | 950 | -20.3% |
| Total current liabilities | 2,624 | 2,704 | 3,074 | 2,204 | 2,985 | 2,895 | 3,521 | 3,548 | +0.8% | |
| Long-term debt |
RESTATED · WAS 13,634
10-Q
|
10,615 | 11,951 | 11,744 | 12,046 | 13,122 | 14,508 | 15,194 | 17,807 | +17.2% |
| Total liabilities |
|
19,737 | 21,782 | 23,589 | 21,565 | 23,758 | 25,392 | 27,172 | 30,230 | +11.3% |
| Net debt |
|
11,437 | 12,923 | 12,289 | 11,990 | 14,050 | 15,258 | 16,285 | 18,250 | +12.1% |
| Stockholders' equity | 4,792 | 5,055 | 6,077 | 7,188 | 7,595 | 8,125 | 8,748 | 9,711 | +11.0% | |
| Net debt / TTM EBITDA | 5.46× | 6.14× | 5.41× | 5.31× | 5.98× | 6.32× | 5.97× | 6.02× | +0.8% | |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-28 ↗